Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Chondrosarcoma × Everolimus × Clear all

Sponsor

Conditions

Breast Neoplasms 41 Carcinoma, Renal Cell 31 Neoplasms 18 Kidney Neoplasms 17 Neuroendocrine Tumors 16 Neoplasm Metastasis 13 Tuberous Sclerosis 10 Prostatic Neoplasms 8 Carcinoma 8 Lymphoma, Mantle-Cell 7 Lymphoma, Large B-Cell, Diffuse 7 Hodgkin Disease 7 Glioma 7 Glioblastoma 7 Astrocytoma 7 Waldenstrom Macroglobulinemia 6 Triple Negative Breast Neoplasms 6 Recurrence 6 Lymphoma 6 Head and Neck Neoplasms 6 Stomach Neoplasms 5 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Neuroendocrine 5 Brain Neoplasms 5 Sezary Syndrome 4 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Mycosis Fungoides 4

Interventions

HhAntag691 2 toripalimab 1 temsirolimus 1 pegfilgrastim 1 pazopanib 1 liposomal doxorubicin 1 enasidenib 1 angiotensin I (1-7) 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Proton Therapy 1 Pharmacogenomic Testing 1 Microarray Analysis 1 Medicare Part B 1 Magnetic Resonance Spectroscopy 1 Immunologic Techniques 1 Gemcitabine 1 Filgrastim 1 Ferrosoferric Oxide 1 Fentanyl 1 Docetaxel 1 Dasatinib 1 Cyproheptadine 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡